Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Hilden

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|July 1, 1994
The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4;11) acute leukemia: molecular and clinical studiesJ M Hilden, J H Kersey
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Tell the childrenJ M Hilden, J Watterson, J Chrastek
Minnesota Medicine|April 1, 1996
Genetic testing for familial cancer. A clinician's perspectiveJ M Hilden, J Watterson, C L Garr
Leukemia & Lymphoma|April 1, 1997
Molecular analysis of infant acute leukemiaJ M Hilden, J L Frestedt, J H Kersey
DNA and Cell Biology|August 1, 1996
AF4/FEL, a gene involved in infant leukemia: sequence variations, gene structure, and possible homology with a genomic sequence on 5q31J L Frestedt, J M Hilden, J H Kersey
Human Immunology|April 1, 1987
DQ beta sequences in HLA-DR4 haplotypesJ M Hilden, J M Curtsinger, J S Cairns, et al.
Genetic Analysis : Biomolecular Engineering|January 1, 1996
Differential expression of AF4/FEL mRNA in human tissuesJ L Frestedt, J M Hilden, R O Moore, et al.
Medical and Pediatric Oncology|January 22, 1998
Misleading leads: Wilms tumor with a metachronous lesion appearing in the remaining kidneyJ M Hilden, W S Brennom, J J Wolpert, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1987
Evolutionary and genetic implications of sequence variation in two nonallelic HLA-DR beta-chain cDNA sequencesJ M Curtsinger, J M Hilden, J S Cairns, et al.
Cancer Research|September 1, 1993
Heterogeneity in MLL/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemiaJ M Hilden, C S Chen, R Moore, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|July 1, 1994
The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4;11) acute leukemia: molecular and clinical studiesJ M Hilden, J H Kersey
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Tell the childrenJ M Hilden, J Watterson, J Chrastek
Minnesota Medicine|April 1, 1996
Genetic testing for familial cancer. A clinician's perspectiveJ M Hilden, J Watterson, C L Garr
Leukemia & Lymphoma|April 1, 1997
Molecular analysis of infant acute leukemiaJ M Hilden, J L Frestedt, J H Kersey
DNA and Cell Biology|August 1, 1996
AF4/FEL, a gene involved in infant leukemia: sequence variations, gene structure, and possible homology with a genomic sequence on 5q31J L Frestedt, J M Hilden, J H Kersey
Human Immunology|April 1, 1987
DQ beta sequences in HLA-DR4 haplotypesJ M Hilden, J M Curtsinger, J S Cairns, et al.
Genetic Analysis : Biomolecular Engineering|January 1, 1996
Differential expression of AF4/FEL mRNA in human tissuesJ L Frestedt, J M Hilden, R O Moore, et al.
Medical and Pediatric Oncology|January 22, 1998
Misleading leads: Wilms tumor with a metachronous lesion appearing in the remaining kidneyJ M Hilden, W S Brennom, J J Wolpert, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1987
Evolutionary and genetic implications of sequence variation in two nonallelic HLA-DR beta-chain cDNA sequencesJ M Curtsinger, J M Hilden, J S Cairns, et al.
Cancer Research|September 1, 1993
Heterogeneity in MLL/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemiaJ M Hilden, C S Chen, R Moore, et al.
Pageof 3